GUIDE provides a simple 5-step approach to optimise the role of the nurse in strengthening shared decision-making between patients with colorectal cancer and their healthcare team. This narrated poster was presented at the ONS Bridge meeting in 2020. Download the summary slides and visit the accredited e-learning on COR2ED Checkpoint

Nina Grenon is a nurse practitioner caring for patients with Gastrointestinal Cancers for the past 22 years, 14 at the Dana-Farber Cancer Institute and the previous 8 years at the Massachusetts General Hospital Cancer Center. She is adjunct faculty at Simmons College, School of Nursing and Health Sciences and serves as a clinical preceptor for nurse practitioner students at Yale University, Simmons College and MGH Institute of Health Professions. She serves on the North America Neuroendocrine Association Tumor Society, regional education committee. Nina Grenon is a frequent national and regional lecturer in colon and pancreatic cancer, published a number of articles in the nursing implication in the management of side effects in patients treated for colon cancer. She is currently on the Oncology Nursing Society Congress Planning Team for 2020. Her research and quality improvement interest include patient and care taker education, specific intervention delivered by front line nurses and the early integrating of palliative care in patients with advanced gastrointestinal malignancies specifically pancreatic cancer.

Sven De Keersmaecker works as a Study Coordinator at the Antwerp University Hospital since 2015, caring for study patients and outpatients. Sven is a graduate nurse since 1997 and worked initially in Intensive Care before moving to work in Oncology in Antwerp in 2000. Over the years, he acted as a nurse navigator in digestive oncology and was involved in the development of coaching programs for patient and health informatics tools to help them with compliance and monitoring of side effects.

Fransen McGinley is a certified physicians assistant in the Gastrointestinal Cancers Clinic at the Stephenson Cancer Center, Oklahoma City. After completing her bachelor’s degree in Microbiology at the University of Oklahoma, she earned her master’s degree from the University of Oklahoma Health Sciences Physician Associate Program. Fransen has more than 12 years of experience as an oncology PA at the University of Oklahoma Health Sciences Center. She is an active member of the National Commission on Certification of Physician Assistants, as well as of the Oklahoma Academy of Physician Assistants.
Programme summary
Play the video now
Other episodes of this series
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI NURSES CONNECT

GI NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

conference-update Conference update
Oncology 
Coming soon! Oncogene-addicted NSCLC highlights from ELCC 2026

Expert insights on the latest NSCLC data

Experts
Prof. Nicolas Girard
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
ISLB Lung Cancer Europe
  • clock 1 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Bayer.
podcast Video podcast
Oncology 
Pre-analytical phase challenges and biomarker testing in HER2+ metastatic breast cancer

Experts
Dr Carlos Barrios, Prof. Gary Tse, Oncology Brothers (Moderators)
Endorsed by
Biomarker Collaborative
  • download Downloadable
    Resources
  • clock 23 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Daiichi Sankyo 
eks
EKS / On-demand webinar
Oncology 
Multiple Myeloma: Is it time to rethink how we sequence treatments?

On-demand materials from an Experts Knowledge Share event

Experts
Prof. Karthik Ramasamy, Dr Joshua Richter, Dr Faisal Basheer, Dr Andrew Charlton
  • download Downloadable
    Resources
  • clock 80 MIN
  • calendar Mar 2026

This programme has been sponsored by Menarini Stemline and is intended for HCPs in the UK only    MAT-GB-SEL-00774
conference-update Conference update

Episode

2

of 2

episode
Oncology Rare diseases Endocrinology 
Actualités du Congrès l’ENETS 2026

Points de vue d’experts sur les dernières données concernant le cancer neuroendocrinien

Experts
Prof. Louis de Mestier, Prof. Timon Vandamme, Dr Alice Durand
  • clock 5 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

Cette vidéo est soutenue par une subvention indépendante à visée éducative d’Ipsen.  Les contenus publiés sur ce site internet sont sous la responsabilité de leurs auteurs. Certaines données scientifiques publiées sur ce site sont susceptibles de ne pas être validées par la commission d’Autorisation de Mise sur le Marché, et ne doivent pas être mises en pratique. Elles doivent être lues et comprises avec le plus grand discernement et sont données dans leur cadre de la diffusion de l’information sur l’état actuel de la recherche auprès de la communauté scientifique internationale  
conference-update Conference update

Episode

1

of 2

episode
Oncology Rare diseases Endocrinology 
Update from ENETS 2026

Experts share their views on latest data in neuroendocrine cancer

Experts
Prof. Louis de Mestier, Prof. Timon Vandamme, Dr Alice Durand
  • clock 5 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

This educational programme is supported by an Independent Educational Grant from Ipsen. The content published on this website is under the responsibility of its authors. Some scientific data published on this website may not have been validated by the relevant Marketing Authorisation Committees and should not be put into practice. It should be read and understood with the utmost discernment and is provided for the purpose of disseminating information on the current state of research to the international scientific community.
patient-support Patient Support
Oncology Hemato-oncology Pediatrics 
Personalised treatment in childhood cancer: A journey through NTRK fusion testing

Experts
Linet Menachery
Endorsed by
NTRKers ICAN international cancer advocacy network Biomarker Collaborative
  • clock 4 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Bayer.